Literature DB >> 16238971

Looking for the right drug for the right patient: a tale of old drugs and new pathways.

Emilio Alba, Nuria Ribelles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16238971     DOI： 10.1007/bf02716582

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  34 in total

Review 1.  New ways of initiating translation in eukaryotes?

Authors:  M Kozak
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 2.  Advances in pharmacogenetics and pharmacogenomics.

Authors:  E S Vesell
Journal:  J Clin Pharmacol       Date:  2000-09       Impact factor: 3.126

3.  Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer.

Authors:  S Marsh; J A McKay; J Cassidy; H L McLeod
Journal:  Int J Oncol       Date:  2001-08       Impact factor: 5.650

4.  Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy.

Authors:  S T Pullarkat; J Stoehlmacher; V Ghaderi; Y P Xiong; S A Ingles; A Sherrod; R Warren; D Tsao-Wei; S Groshen; H J Lenz
Journal:  Pharmacogenomics J       Date:  2001       Impact factor: 3.550

5.  Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients.

Authors:  Marie-Christine Etienne; Jean-Louis Formento; Maurice Chazal; Mireille Francoual; Nicolas Magné; Patricia Formento; André Bourgeon; Jean-François Seitz; Jean-Robert Delpero; Christian Letoublon; Denis Pezet; Gérard Milano
Journal:  Pharmacogenetics       Date:  2004-12

6.  Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.

Authors:  P Piedbois; P Rougier; M Buyse; J Pignon; L Ryan; R Hansen; B Zee; B Weinerman; J Pater; C Leichman; J Macdonald; J Benedetti; J Lokich; J Fryer; G Brufman; R Isacson; A Laplanche; E Levy
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

Review 7.  Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.

Authors:  A F Sobrero; C Aschele; J R Bertino
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

8.  Capecitabine as adjuvant treatment for stage III colon cancer.

Authors:  Chris Twelves; Alfred Wong; Marek P Nowacki; Markus Abt; Howard Burris; Alfredo Carrato; Jim Cassidy; Andrés Cervantes; Jan Fagerberg; Vassilis Georgoulias; Fares Husseini; Duncan Jodrell; Piotr Koralewski; Hendrik Kröning; Jean Maroun; Norbert Marschner; Joseph McKendrick; Marek Pawlicki; Riccardo Rosso; Johannes Schüller; Jean-François Seitz; Borut Stabuc; Jerzy Tujakowski; Guy Van Hazel; Jerzy Zaluski; Werner Scheithauer
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

9.  Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate.

Authors:  Kyoung-Jin Sohn; Ruth Croxford; Zoe Yates; Mark Lucock; Young-In Kim
Journal:  J Natl Cancer Inst       Date:  2004-01-21       Impact factor: 13.506

10.  Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Joshua D Smith; Leonid Kruglyak; Deborah A Nickerson
Journal:  Nat Genet       Date:  2003-03-24       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.